Controversies, Consensus, and Collaboration in the Use of 131 I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association

Michael Tuttle, R.; Ahuja, Sukhjeet; M. Avram, Anca; Bernet, Victor; Bourguet, P.; H. Daniels, Gilbert; Dillehay, Gary; Draganescu, Ciprian; Flux, Glenn; Führer, Dagmar; Giovanella, Luca; S. Greenspan, Bennett; Luster, Markus; Muylle, Kristoff; W. A. Smit, Johannes; Van Nostrand, Douglas; A. Verburg, Frederik; Hegedüs, László

doi:10.1089/thy.2018.0597

Public

Controversies, Consensus, and Collaboration in the Use of 131 I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association

Published in Thyroid • Mar 22, 2019

Authors:

R. Michael Tuttle

Sukhjeet Ahuja

Anca M. Avram

Abstract

Background: Publication of the 2015 American Thyroid Association (ATA) management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer was met with disagreement by the extended nuclear medicine community with regard to some of the recommendations related to the diagno...

Subject

Thyroid cancer

Medicine

Statement (logic)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!